Standard Biotools (LAB) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -168.00 |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 1,569.00 |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 2,862.00 |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 123.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -825.00 |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -201.00 |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -527.00 |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 3,021.00 |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | -6,321.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,321.00 |
| Mar 31, 2026 | 696.00 |
| Dec 31, 2025 | -2,544.00 |
| Sep 30, 2025 | -5,528.00 |
| Jun 30, 2025 | 8,729.00 |
| Mar 31, 2025 | -2,960.00 |
| Sep 30, 2024 | -6,001.00 |
| Jun 30, 2024 | -7,720.00 |
| Mar 31, 2024 | -7,324.00 |
| Dec 31, 2023 | -3,797.00 |
| Sep 30, 2023 | -6,976.00 |
| Jun 30, 2023 | -1,040.00 |
| Mar 31, 2023 | -1,195.00 |
| Dec 31, 2022 | -4,983.00 |
| Sep 30, 2022 | -6,104.00 |
| Jun 30, 2022 | -15,347.00 |
| Mar 31, 2022 | -5,659.00 |
| Sep 30, 2021 | -2,073.00 |
| Jun 30, 2021 | -896.00 |
| Mar 31, 2021 | -888.00 |